A study published in Nature Cell Research is reshaping the way scientists view the human genome and its potential for yielding novel insights into cell biology and cancer development. The research, conducted by a team of Chinese scientists, presents what may be the most extensive characterization to date of previously unannotated peptides many of which originate from genomic regions once thought to be noncoding.
At the heart of the study is a concerted effort to address a longstanding blind spot in human genetics: the functional potential of short open reading frames (sORFs), particularly those found in long noncoding RNAs. While only about 1% of the human genome is traditionally recognized as protein-coding, the remainder, often dismissed as nonfunctional, has begun to reveal new and surprising roles in recent years. This latest work pushes that boundary further.
The researchers compiled a vast reference library of over 11 million predicted open reading frames, a scale not previously attempted in peptidomics. To interrogate this extensive dataset, they used an advanced ultrafiltration tandem mass spectrometry approach, a technique well-suited to detecting the short, low-abundance peptides that often elude conventional methods. The result was the identification of 8,945 novel peptides across normal gastric tissues, gastric cancer samples, and cell lines. Notably, nearly half of these peptides originated from noncoding RNAs.
Beyond discovery, the study moved into functional territory. Using CRISPR-based gene editing, the researchers screened for peptides involved in tumor cell proliferation and identified 1,161 candidates with apparent roles in cancer cell growth. Additional validation through methods like Flag-tag knockin and structural prediction models using AlphaFold2, revealed that many of these peptides participate in essential cellular processes such as mitochondrial complex assembly and lipid metabolism.
Among the most notable findings were four peptides, pep1-nc-OLMALINC, pep5-nc-TRHDE-AS1, pep-nc-ZNF436-AS1, and pep2-nc-AC027045.3, shown to influence mitochondrial function, cholesterol metabolism, and tumor progression. Two of these peptides significantly impacted tumor growth in animal models, and all four were linked to clinical outcomes in gastric cancer patients.
This study stands out not only for its scale but also for its integrative approach. By combining bioinformatics, proteomics, CRISPR screening, and AI-based protein modeling, the team produced a multidimensional view of the so-called noncanonical proteome a term used to describe the collection of protein products not currently catalogued in traditional gene annotations.